Head-to-head Study of 68Ga-MGS5 Versus 68Ga-DOTATATE PET/CT in Patients With Medullary Thyroid Carcinoma

Abroad (travel likely)RecruitingPHASE1

Conditions

Medullary Thyroid Carcinoma

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

Department of Nuclear Medicine, First Affiliated Hospital of Fujian Medical University, Fuzhou, Fujian, China
Contact: Study coordinator (Weibing Miao, MD) · miaoweibing@126.com · +86 591 87981618
Contact: Study coordinator (Zhenying Chen, MB) · 714144972@qq.com · +86 591 87981619

Study leads

Weibing Miao
Principal Investigator
First Affiliated Hospital of Fujian Medical University

View source on ClinicalTrials.gov

Similar trials

Other trials that are currently recruiting and may be relevant based on condition, treatment, phase, or location

Research on the Application of 68Ga-DOTA-CCK-FS PET/CT in MTC

Medullary Thyroid Carcinoma

Abroad (travel likely)Recruiting

Beijing, China

CTR-FAPI-guided Precision Surgery for Newly Diagnosed MTC

Medullary Thyroid Carcinoma

Abroad (travel likely)RecruitingPHASE3

Beijing, China